Impact of Altered Methylation in Cytokine Signaling and Proteasome Function in Alcohol and Viral-Mediated Diseases

Alcoholism: Clinical and Experimental Research

Volumn 37, Issue 1, 2013, Pages 1-7

  Kharbanda, Kusum K ^a,b,c   Bardag Gorce, Fawzia ^d   Barve, Shirish ^e   Molina, Patricia E ^f   Osna, Natalia A ^a,b  

^a VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c Department of Internal Medicine Biochemistry and Molecular Biology ^*  (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

^e University of Louisville School of Medicine   (United States)

^f LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol; Cytokine; Methylation; Viral

Indexed keywords

BETAINE; CYCLIC AMP; CYTOCHROME P450 2E1; CYTOKINE; HISTONE; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PHOSPHODIESTERASE IV; PROTEASOME; S ADENOSYLMETHIONINE; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOLISM; ANTIGEN PRESENTATION; CYTOKINE PRODUCTION; GENE REPRESSION; GENETIC TRANSCRIPTION; HEPATITIS C VIRUS; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; LIVER CELL; LIVER METABOLISM; MACROPHAGE; METHYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE; VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; BETAINE; ETHANOL; HEPATITIS C; HUMANS; INTERFERONS; LIVER; LIVER DISEASES, ALCOHOLIC; METHIONINE; METHYLATION; METHYLTRANSFERASES; PROTEASOME ENDOPEPTIDASE COMPLEX; S-ADENOSYLMETHIONINE; TUMOR NECROSIS FACTOR-ALPHA;

HEPATITIS C VIRUS;

EID: 84871964152     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2012.01840.x     Document Type: Review

References (57)

1. Bardag-Gorce F (2009) Nuclear effects of ethanol-induced proteasome inhibition in liver cells. World J Gastroenterol 15:1163-1167.
2. Bardag-Gorce F (2010) Effects of ethanol on the proteasome interacting proteins. World J Gastroenterol 16:1349-1357.
3. Bardag-Gorce F (2011) Proteasome inhibitor treatment in alcoholic liver disease. World J Gastroenterol 17:5.
4. Bardag-Gorce F, Dedes J, French BA, Oliva JV, Li J, French SW (2007) Mallory body formation is associated with epigenetic phenotypic change in hepatocytes in vivo. Exp Mol Pathol 83:160-168.
5. Bardag-Gorce F, French BA, Nan L, Song H, Nguyen SK, Yong H, Dede J, French SW (2006) CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation. Exp Mol Pathol 81:191-201.
6. Bardag-Gorce F, Oliva J, Li J, French BA, French SW (2010) SAMe prevents the induction of the immunoproteasome and preserves the 26S proteasome in the DDC-induced MDB mouse model. Exp Mol Pathol 88:353-362.
7. Bardag-Gorce F, Oliva J, Lin A, Li J, French BA, French SW (2011) Proteasome inhibition up regulates liver antioxidant enzymes in a rat model of alcoholic liver disease. Exp Mol Pathol 90:123-130.
8. Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS (1990) Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 112:917-920.
9. Bjork L (1976) Left ventricular angiocardiography in coronary artery disease. Radiologe 16:105-109.
10. Clarke S, Banfield K (2001) S-adenosylmethionine-dependent methyltransferases, in Homocysteine in Health and Disease (Carmel R, Jacobsen DW eds), pp 63-78. Cambridge University Press, Cambridge.
11. Conti M, Beavo J (2007) Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 76:481-511.
12. Donohue TM, Osna NA, Clemens DL (2006) Recombinant Hep G2 cells that express alcohol dehydrogenase and cytochrome P450 2E1 as a model of ethanol-elicited cytotoxicity. Int J Biochem Cell Biol 38:92-101.
13. Donohue TM Jr, Cederbaum AI, French SW, Barve S, Gao B, Osna NA (2007) Role of the proteasome in ethanol-induced liver pathology. Alcohol Clin Exp Res 31:1446-1459.
14. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL (1990) Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 14:255-259.
15. French SW, Oliva J, Li J, French BA, Bardag-Gorce F (2010) Ethanol induced proteasome inhibition is associated with changes in methylation: effect of S-adenosylmethionine. Alcohol Clin Exp Res 34:73A, Abstract S230.
16. Gobejishvili L, Avila DV, Barker DF, Ghare S, Henderson D, Brock GN, Kirpich IA, Joshi-Barve S, Mokshagundam SP, McClain CJ, Barve S (2011) S-adenosylmethionine decreases lipopolysaccharide-induced phosphodiesterase 4B2 and attenuates tumor necrosis factor expression via cAMP/protein kinase A pathway. J Pharmacol Exp Ther 337:433-443.
17. Gobejishvili L, Barve S, Joshi-Barve S, McClain C (2008) Enhanced PDE4B expression augments LPS-inducible TNF expression in ethanol-primed monocytes: relevance to alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 295:G718-G724.
18. Gobejishvili L, Barve S, Joshi-Barve S, Uriarte S, Song Z, McClain C (2006) Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-kappaB activity and TNF expression: relevance to alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 291:G681-G688.
19. Gomes AV, Young GW, Wang Y, Zong C, Eghbali M, Drews O, Lu H, Stefani E, Ping P (2009) Contrasting proteome biology and functional heterogeneity of the 20 S proteasome complexes in mammalian tissues. Mol Cell Proteomics 8:302-315.
20. Houslay MD (2010) Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown. Trends Biochem Sci 35:91-100.
21. Hublitz P, Albert M, Peters AH (2009) Mechanisms of transcriptional repression by histone lysne methylation. Int J Dev Biol 53:335-354.
22. Jin SL, Conti M (2002) Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses. Proc Natl Acad Sci U S A 99:7628-7633.
23. Jin SL, Lan L, Zoudilova M, Conti M (2005) Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages. J Immunol 175:1523-1531.
24. Kharbanda KK (2009) Alcoholic liver disease and methionine metabolism. Semin Liver Dis 29:155-165.
25. Kharbanda KK, Barak AJ (2005) Defects in methionine metabolism: Its role in ethanol-induced liver injury, in Comprehensive Handbook of Alcohol-Related Pathology, Vol 2 (Preedy VR, Watson RR eds), pp 735-747. Elsevier Academic Press, San Diego, CA.
26. Kinyamu HK, Archer TK (2007) Proteasome activity modulates chromatin modifications and RNA polymerase II phosphorylation to enhance glucocorticoid receptor-mediated transcription. Mol Cell Biol 27:4891-4904.
27. Kouzarides T (2002) Histone methylation in transcriptional control. Curr Opin Genet Dev 12:198-209.
28. Li J, Bardag-Gorce F, Dedes J, French BA, Amidi F, Oliva J, French SW (2008) S-adenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting the epigenetic memory. Hepatology 47:613-624.
29. McClain CJ, Barve S, Deaciuc I, Kugelmas M, Hill D (1999) Cytokines in alcoholic liver disease. Semin Liver Dis 19:205-219.
30. McClain CJ, Cohen DA (1989) Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9:349-351.
31. Molina PE, McNurlan M, Rathmacher J, Lang CH, Zambell KL, Purcell J, Bohm RP, Zhang P, Bagby GJ, Nelson S (2006) Chronic alcohol accentuates nutritional, metabolic, and immune alterations during asymptomatic simian immunodeficiency virus infection. Alcohol Clin Exp Res 30:2065-2078.
32. Mowen KA, Tang J, Zhu W, Schurter BT, Shuai K, Herschman HR, David M (2001) Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell 104:731-741.
33. Ohlinger W, Dinges HP, Zatloukal K, Mair S, Gollowitsch F, Denk H (1993) Immunohistochemical detection of tumor necrosis factor-alpha, other cytokines and adhesion molecules in human livers with alcoholic hepatitis. Virchows Arch A Pathol Anat Histopathol 423:169-176.
34. Oliva J, Bardag-Gorce F, Li J, French BA, Nguyen SK, Lu SC, French SW (2009a) Betaine prevents Mallory-Denk body formation in drug-primed mice by epigenetic mechanisms. Exp Mol Pathol 86:77-86.
35. Oliva J, Bardag-Gorce F, Lin A, French BA, French SW (2010a) The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomes. Exp Mol Pathol 89:1-8.
36. Oliva J, Dedes J, Li J, French SW, Bardag-Gorce F (2009b) Epigenetics of proteasome inhibition in the liver of rats fed ethanol chronically. World J Gastroenterol 15:705-712.
37. Oliva J, Lin A, Li J, French BA, French SW, Bardag-Gorce F (2010b) Proteasome inhibitor treatment reduces hepatic steatosis by decreasing lipogenic enzyme gene expression. Alcohol Clin Exp Res 34:87A, Abstract #308.
38. O'Shea JJ, Gadina M, Schreiber RD (2002) Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109(Suppl):S121-S131.
39. Osna NA, Clemens DL, Donohue TM Jr (2005) Ethanol metabolism alters interferon gamma signaling in recombinant HepG2 cells. Hepatology 42:1109-1117.
40. Osna NA, Donohue TM Jr (2007) Implication of altered proteasome function in alcoholic liver injury. World J Gastroenterol 13:4931-4937.
41. Osna N, Donohue T, White R, Beard M, Kharbanda K (2008) Ethanol and hepatitis C viral proteins regulate interferon signaling in liver cells via impaired methylation of STAT1. Hepatology 48:75A.
42. Osna NA, White RL, Donohue TM Jr, Beard MR, Tuma DJ, Kharbanda KK (2010) Impaired methylation as a novel mechanism for proteasome suppression in liver cells. Biochem Biophys Res Commun 391:1291-1296.
43. Osna NA, White RL, Thiele GM, Donohue TM Jr (2009) Ethanol metabolism alters major histocompatibility complex class I-restricted antigen presentation in liver cells. Hepatology 49:1308-1315.
44. Ou X, Yang H, Ramani K, Ara AI, Chen H, Mato JM, Lu SC (2007) Inhibition of human betaine-homocysteine methyltransferase expression by S-adenosylmethionine and methylthioadenosine. Biochem J 401:87-96.
45. Pal-Bhadra M, Bhadra U, Jackson DE, Mamatha L, Park PH, Shukla SD (2007) Distinct methylation patterns in histone H3 at Lys-4 and Lys-9 correlate with up- & down-regulation of genes by ethanol in hepatocytes. Life Sci 81:979-987.
46. Safdar K, Schiff ER (2004) Alcohol and hepatitis C. Semin Liver Dis 24:305-315.
47. Shukla SD, Aroor AR (2006) Epigenetic effects of ethanol on liver and gastrointestinal injury. World J Gastroenterol 12:5265-5271.
48. Shukla SD, Velazquez J, French SW, Lu SC, Ticku MK, Zakhari S (2008) Emerging role of epigenetics in the actions of alcohol. Alcohol Clin Exp Res 32:1525-1534.
49. Song Z, Uriarte S, Sahoo R, Chen T, Barve S, Hill D, McClain C (2005) S-adenosylmethionine (SAMe) modulates interleukin-10 and interleukin-6, but not TNF, production via the adenosine (A2) receptor. Biochim Biophys Acta 1743:205-213.
50. Szabo G, Aloman C, Polyak SJ, Weinman SA, Wands J, Zakhari S (2006) Hepatitis C infection and alcohol use: a dangerous mix for the liver and antiviral immunity. Alcohol Clin Exp Res 30:709-719.
51. Szutorisz H, Georgiou A, Tora L, Dillon N (2006) The proteasome restricts permissive transcription at tissue-specific gene loci in embryonic stem cells. Cell 127:1375-1388.
52. Veal N, Hsieh CL, Xiong S, Mato JM, Lu S, Tsukamoto H (2004) Inhibition of lipopolysaccharide-stimulated TNF-alpha promoter activity by S-adenosylmethionine and 5′-methylthioadenosine. Am J Physiol Gastrointest Liver Physiol 287:G352-G362.
53. Vidali M, Occhino G, Ivaldi A, Rigamonti C, Sartori M, Albano E (2008) Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C. Am J Gastroenterol 103:147-153.
54. Wang H, An W, Cao R, Xia L, Erdjument-Bromage H, Chatton B, Tempst P, Roeder RG, Zhang Y (2003) mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression. Mol Cell 12:475-487.
55. Watson WH, Zhao Y, Chawla RK (1999) S-adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for tumour necrosis factor alpha. Biochem J 342:21-25.
56. Yang H, Ara AI, Magilnick N, Xia M, Ramani K, Chen H, Lee TD, Mato JM, Lu SC (2008) Expression pattern, regulation, and functions of methionine adenosyltransferase 2beta splicing variants in hepatoma cells. Gastroenterology 134:281-291.
57. Zatloukal K, French SW, Stumptner C, Strnad P, Harada M, Toivola DM, Cadrin M, Omary MB (2007) From Mallory to Mallory-Denk bodies: what, how and why? Exp Cell Res 313:2033-2049.